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Abstract: Increased physical activity (PA) affects outcomes in patients with anorexia nervosa (AN).
To objectively assess PA patterns of hospitalized AN patients in comparison with healthy, outpatient
controls (HC), and to analyze the effect of PA on Body Mass Index (BMI) change in patients with AN,
we measured PA in 50 female patients with AN (median age = 25 years, range = 18–52 years; mean
BMI = 14.4 ± 2.0 kg/m2) at the initiation of inpatient treatment and in 30 female healthy controls
(median age = 26 years, range = 19–53 years; mean BMI = 21.3 ± 1.7 kg/m2) using the SenseWear™
armband. Duration of inpatient stay and weight at discharge were abstracted from medical records.
Compared with controls, AN patients spent more time in very light-intensity physical activity (VLPA)
(median VLPA = 647 vs. 566 min/day, p = 0.004) and light-intensity physical activity (LPA) (median
LPA = 126 vs. 84 min/day, p < 0.001) and less time in moderate-intensity physical activity (MPA)
(median MPA = 82 vs. 114 min/day, p = 0.022) and vigorous physical activity (VPA) (median VPA = 0
vs. 16 min/day, p < 0.001). PA and BMI increase were not associated in a linear model, and BMI
increase was mostly explained by lower admission BMI and longer inpatient stay. In a non-linear
model, an influence of PA on BMI increase seemed probable (jack knife validation, r2 = 0.203; p < 0.001).
No direct association was observed between physical inactivity and BMI increase in AN. An altered
PA pattern exists in AN patients compared to controls, yet the origin and consequences thereof
deserve further investigation.
Keywords: accelerometry; eating disorders; motor restlessness; physical inactivity
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1. Introduction
The role of increased physical activity (PA) for the onset and maintenance of anorexia nervosa
(AN) is increasingly recognized. Being associated with a longer duration of inpatient treatment [1]
and higher rates of a chronic outcome [2] as well as drop-out from treatment [3], increased PA can
be regarded as a significant factor in the persistence of the disease [4]. However, high level PA is
addressed insufficiently by current research [5]. As a consequence, a deeper understanding of the
mechanisms underlying altered PA in AN as well as for the development of suitable therapeutic
strategies to manage PA during weight restoration efforts are urgently warranted to improve outcomes
for patients with AN.
Elevated levels of physical activity have been observed in 30–80% of patients suffering from
AN [6,7], with this high range probably resulting from varying methods of PA measurement [8].
When assessed with subjective measurement tools including exercise questionnaires, patients reported
higher total PA in comparison with a control group, yet simultaneous objective PA assessment using
actigraphy yielded similar PA levels [9], suggesting that self-report overestimated PA in patients with
AN and that objective assessments are needed to obtain accurate results. In addition, PA behavior
is complex and has multiple dimensions; therefore, objective quantification of PA targets different
components. Previous studies on objectively assessed PA in AN have yielded mixed results, with some
reporting no differences in time spent in moderate to vigorous and daytime PA [10], or fidgeting [8],
while others reported increased moderate to vigorous PA duration [3] and seated non-exercise PA [11]
between AN inpatients and controls.
In a previous study [12], we focused on a potential link between high PA in AN and
hypoleptinemia using a multisensor body monitor (Sensewear™ armband) for objective PA detection
in hospitalized adults with AN. Results indicated that the use and interpretation of accelerometry,
employed to objectively assess PA in AN patients, needs to be developed further and should also
include parameters of physical inactivity. Building on the previous findings based on simple step count,
the present study focused on a more detailed analysis of an expanded set of objectively measured
PA patterns and intensities in adult females with AN, including inactivity parameters and adding a
comparison to normal weight controls. We aimed to investigate the relationship between different
PA patterns and BMI increase during inpatient treatment. We hypothesized that during inpatient
treatment (I), hospitalized adult AN patients show increased low intensity PA in comparison with
healthy controls, (II) increased low-level PA and BMI increase are inversely related, and (III) physical
inactivity and BMI increase are directly related.
2. Subjects and Methods
2.1. Study Population
We enrolled 50 female adults with AN who were admitted to the Department of Psychosomatic
Medicine at Charité—Universitätsmedizin Berlin for inpatient treatment of AN between 2011 and
2016. Patient inclusion criteria were: A diagnosis of AN according to ICD-10 (International Statistical
Classification of Diseases and Related Health Problems, 10th Revision), restrictive, purging or atypical
type, as well as a BMI < 17.5 kg/m2. Exclusion criteria were: age <18 years, current pregnancy or
a diagnosed psychotic episode. Information about the duration of the illness, comorbidities as well
as medication at the beginning and end of the treatment program were retrieved from anamnestic
data and medical reports. Between 2015 and 2016, we also recruited 30 sex-matched and similar aged
normal weight healthy controls (HC), consisting mostly of clinical staff and relatives thereof. A BMI
between 18.5 and 25 kg/m2 served as inclusion criteria. Exclusion criteria were: Any known major
medical or psychiatric disease and any condition with significant influence on PA. All participants
gave written informed consent, and the study was approved by the institutional ethics committee of
the Charité—Universitätsmedizin Berlin.
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2.2. Anthropometry
Weight of all patients was measured to the nearest 0.1 kg via a digital scale (Seca 771,
Vogel & Halke, Hamburg, Germany) and height to the nearest 0.5 cm via a stadiometer (Seca 220
Stadiometer, Vogel & Halke, Hamburg, Germany) [13]. Measurements took place in the morning
between 7 and 8 a.m. after overnight fasting and in underwear. Weight of the controls was measured
after a 2-h fast using a chair scale (MCB300K100M, KERN & Sohn GmbH, Balingen, Germany) and
height was measured using a stadiometer (Vogel & Halke). BMI was calculated as kg/m2.
2.3. Bioelectrical Impedance Analysis
Whole-body bioimpedance was measured by Nutriguard-M (Data Input, Darmstadt, Germany;
electrodes: Bianostic-AT, Data Input) as part of the patients’ clinical measurements. For bioimpedance
analysis (BIA) of the normal-weight controls Biacorpus RX 4004 (MEDICAL HealthCare GmbH,
Karlsruhe, Germany; Electrodes: BIA Classictabs, Medical HealthCare GmbH, Karlsruhe, Germany)
was used. Patients and controls were weighed after fasting for at least 2 h, voiding and an equilibration
period in a supine position. The equilibration period of both AN patients and controls lasted at least
10 min. BIA was carried out in accordance to the manufacturer’s instructions, and body composition
was calculated with Body Comp software (Version 9.0, Professional Scientific, Medical Health Care
GmbH, Karlsruhe, Germany).
2.4. PA Assessment
PA was measured in AN patients after inpatient admission and inclusion into the study. Using a
portable armband device (SenseWear™ PRO3 armband; BodyMedia, Inc., Pittsburgh, PA, USA), PA
was continuously detected over a 3-day period (Friday to Sunday). During the time of PA detection,
the study population was not restricted regarding their daily physical activity [13]. A day was included
into data analysis if the armband had been worn for at least 20.5 h [13]. Measurements of controls
took place while they stayed in their usual environment and by using the SenseWear™ PRO3 or
the SenseWear™ MF armband. According to a statement of the manufacturer from 15 March 2011,
the Sensewear Pro 3 and MF models were shown to be functionally equivalent in terms of sensor
technology and data analysis (manufacturers statement on equivalency available on request).
The Sensewear armband is a multi-sensor device worn on the upper dominant arm which enables
a continuous physiological PA detection [14] by measuring parameters such as heat flow, galvanic
skin response (GSR), body temperature and near-body temperature [15]. An integrated two-axial
accelerometer captures the movement of the upper arm as well as the position of the body [14].
The information captured by the five sensors and participant characteristics (age, sex, weight, height,
smoker or non-smoker and handedness) [16] are integrated and analyzed by a proprietary software
(SenseWear™ Software, Version 8.0, BodyMedia, Inc., Pittsburgh, PA, USA). This program is based
upon algorithms of the manufacturer and able to analyze the collected raw data at different metabolic
equivalent (MET) values. The latter represents a standardized indicator which is independent of time,
body weight and sex [15]. One MET is equivalent to 1 kcal/h/kg body weight and serves as useful
parameter to describe the energy expenditure [17] and intensity [15] of a specific activity. The MET
value ranges from 1 MET while at rest [17] and 1.1 METs when driving in a car to 2–4 METs when
doing housework [15], and can reach maximum values of 20 METs when doing excessive sports [15].
According to previous studies, we used six different MET categories to classify different activity
intensities of PA within our AN and control group:
• A MET-value ≤1.0 was defined as the rate of energy expenditure while at rest [17].
• Activities with a MET-value ≤1.8 were considered as sedentary behavior [18].
• Thus, we concluded to form a new category ranging from ≥1.1 to ≤1.8 METs to describe very
light-intensity physical activities (VLPA).
• Light-intensity physical activities (LPA) were defined as MET-values >1.8 and <3 [18].
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• Moderate-intensity activities (MPA) were defined as ≥3 METs to <6 METs [17,18].
• Vigorous-intensity activities (VPA) were divided firstly into MET-values ranging from ≥6 to ≤9,
and secondly into values >9 METs [3].
2.5. Statistical Analysis
Based on a prior study of 11 AN patients and 10 HCs whose activity was measured with a
shoe-based accelerometer at three time points: (I) while eating lunch, (II) filling out questionnaires,
and (III) watching television for 1 h, power was sufficient with 19 analyzed individuals to demonstrate
a significant difference in total PA levels (df = 1.19, f = 5.68, p = 0.03) [11]. However, we aimed to assess
activity continuously for 3 days and parse the analyses into six different PA intensity levels, i.e., (I) at
rest, (II) very light, (III) light, (IV) moderate, (V) vigorous and (VI) vigorous >9 METs. Therefore, we
assumed that at least four times more patients (i.e., n = 44) would be required to have sufficient power.
For organizational purposes we capped HCs at n = 30 (assuming less heterogeneity among HCs); we
increased the sample size of AN patients to n = 50.
A p-value of <0.05 was set as the significance threshold. All variables were tested in a
two-sided fashion. All data are presented as mean ± standard deviation (SD) if following a normal
distribution, otherwise as median (25th/75th percentile), or absolute frequency (relative frequency %).
Quartiles were computed using R type 8 so that the resulting quantile estimates were approximately
median-unbiased, regardless of the distribution. Data following a Gaussian distribution were analyzed
by t-tests. Wilcoxon tests were applied for group differences for quantitative response variables
not following a Gaussian distribution. Analyses for categories were performed by Fisher’s exact
test. To test the relationship between BMI change and various potential predictors, univariate and
multivariate linear models were computed. A regression tree was computed, as this approach does not
make assumptions on distributions or linearity. This machine learning technique computes a series of
prediction thresholds to split a data set. Given our relatively small sample, splitting the data set into
learning and test sets was not feasible; therefore, we applied a jack-knife procedure, classifying each
subject based on a tree build from the remaining patients. Statistical analyses were computed using R
version 3.4.2, R Core Team 2017.
3. Results
3.1. Characterization of the Study Population Including Medical Details, Comorbidities, Medications,
and Body Composition
Table 1 shows the patients’ demographic characteristics and body composition data upon hospital
admission compared to the healthy control group. The two study groups did not significantly differ in
age (p = 0.057). Body weight, BMI, body fat, and lean mass were significantly lower in patients with
AN compared to controls (all: p < 0.001; Table 1). Regarding phase angle, i.e., the ratio of body cell
mass to fat-free mass as an indicator of cellular health and integrity, AN patients had significantly
lower values than controls (p < 0.001; Table 1).
Medical details, comorbidities, and current medications of the study populations are summarized
in a supplemental table (Supplementary Table S1). Forty-eight percent of the patients were diagnosed
with restrictive AN, 26% with purging AN, and 26% with atypical AN. In terms of comorbidities, AN
patients had significantly more pericardial effusion (p < 0.001), episodes of depression (p < 0.001), and
at least one comorbidity (AN = 96% vs. C = 33%, p < 0.001). No statistically significant differences
existed for other medical disorders. In terms of medication, a significant difference between both
groups existed only for psychopharmacological treatment, with none of the controls (C) but 16% of
the AN patients receiving medication on admission (p = 0.021). No significant difference existed for
oral contraceptives (p = 0.052), L-thyroxine (p = 0.632), or taking no medication (AN, 35% vs. C, 37%;
p = 1.000).
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Table 1. Demographic characteristics and bioimpedance data in patients with anorexia nervosa on
admission and in the healthy control group.
Measurement Parameters Anorexia Nervosa Baseline (n = 50) Controls (n = 30) p
Demographic parameters
Age (years) 25 (21/30) 26 (23/35) 0.057
Weight (kg) 39.9 ± 6.6 (28.4–58.8) 60.5 ± 5.8 (51.2–71.9) <0.001
Height (cm) 166 ± 7 (152–185) 169 ± 6 (159–180) 0.128
BMI (kg/m2) 14.4 ± 2.0 (8.9–17.7) 21.3 ± 1.7 (18.8–25.0) <0.001
Duration of illness (months) 72 (15/134) N/A
Body composition
Phase angle (◦) 4.5 (3.8/5.1) 5.9 (5.5/6.4) <0.001
Fat mass (kg) 2.9 ± 2.7 (1–12.5) 16.0 ± 3.1 (11.3–22.5) <0.001
Fat mass (%) 6.7 ± 5.2 (2.1–21.6) 26 ± 3 (21–32) <0.001
Fat-free mass (kg) 37 ± 4 (27–46) 44 ± 3 (39–53) <0.001
Fat-free mass (%) 93 ± 5 (78–98) 74 ± 3 (68–79) <0.001
Data are expressed as mean ± SD (range) or as median (25th/75th percentile). BMI, Body Mass Index; N/A, not
applicable; AN, anorexia nervosa.
3.2. Comparison of Physical Activity and MET Intensities
PA data and time spent in different levels of physical activity of 50 hospitalized AN patients
compared to 30 ambulatory healthy controls are outlined in Table 2. Both groups engaged in similar
levels of activity in terms of average steps and total distance per day. However, patients with AN
had a greater range regarding the step count; 2479–31876 vs. 6507–22948 steps (Table 2). Significant
differences were observed in daily average METs with patients presenting lower median values than
controls. Patients with AN spent significantly more time in very low (p = 0.004) and low (p < 0.001)
levels of PA than controls. Conversely, AN patients spent significantly less time in PA below the very
low PA level (p < 0.001), in moderate (p = 0.022) as well as in 6–9 MET vigorous activity level (p < 0.001;
Table 2). However, no significant differences were found for markers of physical inactivity: Both
groups spent nearly the same duration of time on recumbency and sleep.
Table 2. Physical activity and the division into different MET cut-offs in patients with anorexia nervosa
on admission and in the healthy control group.
Measurement Parameters Anorexia Nervosa Baseline(n = 50) Controls (n = 30) p
Physical activity
Number of steps per day 11,305 ± 6064 (2479–31,876) 11,098 ± 3973 (6507–22,948) 0.854
Total distance (km/day) 10.2 ± 5.5 (2.3–25.2) 9.8 ± 4.0 (4.6–19.2) 0.769
Metabolic equivalents (METs per day) 1.40 (1.40/1.60) 1.70 (1.50/1.80) <0.001
Duration of recumbency (min/day) 483 (443/527) 500 (440/560) 0.348
Duration of sleep (min/day) 427 (375/457) 408 (363/484) 0.842
PA ≤ 1 METs duration (min/day) 496 (448/536) 588 (502/643) <0.001
VLPA 1.1–1.8 METs duration (min/day) 647 (569/703) 566 (499/631) 0.004
LPA 1.8–3 METs duration (min/day) 126 (92/188) 84 (71/108) <0.001
MPA 3–6 METs duration (min/day) 82 (44/130) 114 (79/165) 0.022
VPA 6–9 METs duration (min/day) 0 (0/3) 16 (8/35) <0.001
VPA > 9 METs duration (min/day) 0.0 (0.0/0.0) 0.0 (0.0/3.2) 0.063
Data are expressed as mean ± SD (range) or as median (25th/75th percentile). LPA, light-intensity physical
activity; MET, metabolic equivalent; MPA, moderate-intensity physical activity; PA, physical activity; VLPA, very
light-intensity physical activity; VPA, vigorous-intensity physical activity.
3.3. BMI Change
Table 3 summarizes clinical outcome parameters of AN patients on admission and at discharge
from inpatient treatment. On average, AN patients achieved a weight gain of 2.1 ± 2.3 kg during
the 32-day (25th percentile: 26 days; 75th percentile: 63 days) inpatient treatment program. The BMI
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increased by 0.7 ± 0.8 kg/m2, which is equivalent to a BMI increase of 4%. The mean rate of weight
gain in AN was 0.29 kg/week and ranged from −0.44 kg/week up to 1.35 kg/week. Seven (14%) out
of the 50 AN patients lost weight during their inpatient stay.
Table 3. Clinical outcome parameters of patients with anorexia nervosa.
Measurement Parameters Anorexia Nervosa Baseline(n = 50)
Anorexia Nervosa Discharge
(n = 50) p
Clinical outcome
Weight (kg) 39.9 ± 6.6 (28.4–58.8) 42.0 ± 6.2 (31.4–59.7) <0.001
Total weight gain (kg) - 2.1 ± 2.3 (−1.4–9.6)
BMI (kg/m2) 14.4 ± 2.0 (8.9–17.7) 15.2 ± 1.8 (11.7–18.3) <0.001
BMI increase (kg/ m2) - 0.7 ± 0.8 (−0.5–2.8)
BMI increase (%) - 4 (1/10)
Data are expressed as mean ± SD (range) or as median (25th/75th percentile); BMI, Body Mass Index.
3.4. Association between Physical Activity and Clinical Outcome
In an univariate regression analysis with BMI increase in % as the dependent variable and a range
of potential predictive factors as independent variables (length of inpatient stay, phase angle, BMI on
admission, steps, total distance, PA at different MET intensities, duration of sleep and recumbency),
only length of inpatient stay (r = 0.154; p < 0.001), phase angle (r = −2.95; p = 0.002) and BMI on
admission (r = −1.99; p < 0.001) were significant predictors (presented in Figure 1 with Spearman
rank correlation). In a multivariable model, length of inpatient stay (p < 0.001) and BMI on admission
(p = 0.029) remained significant predictors and duration of sleep became significant (r = −0.0107;
p = 0.019) as well. In addition, for MPA a trend (r = 0.0111; p = 0.089) towards becoming a significant
positive predictor of BMI increase was observed.
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Few studies have objectively measured low intensity PA in AN inpatients compared with healthy
controls. Our findings demonstrating increased low intensity PA are consistent with a previous study
using a shoe-based monitor [11]. Using the SenseWear armband, El Ghoch et al. [3] also observed
that AN patients spent less time in high intensity PA, yet contrary to our findings time spent in
light-intensity PA did not differ between groups and the patients showed a significantly higher
moderate and vigorous PA duration. The division into two low intensity MET categories (1.1–1.8 and
1.8–3) in the present study as opposed to one category (1.1–3 METs) in the study by El Ghoch [3] may
explain the different and more detailed results. Differences in time spent with moderate to vigorous
PA might relate to varying approaches with respect to the restriction of PA on the wards or to practical
opportunities to exercise in the environment outside the ward. The choice of different PA assessment
tools should also be taken into account: When assessing PA with movement sensors, there was no
difference in time spent on “fidgeting” (operationalized as “body position change counts”) between
AN patients and controls [8]. Yet, the authors of that study mentioned problems with measurement
technology consisting of several leads and wires, which might have affected compliance and PA
behavior of the study participants.
A better understanding of the origin of distinct PA patterns in AN patients is warranted.
Increased light PA in AN might be a consequence of negative energy balance resulting in a foraging
response to increase PA to find food [19,20] or linked with a distinct phenotype characterized
by disturbed energy homeostasis specifically associated with increased PA despite severe weight
loss [6,21]. Further origins for increased light PA in AN might be an attempt of emotion regulation [6,22]
or the desire to lose weight [4,23]. Interestingly, when interviewed 57 years after participating in the
Minnesota starvation experiment in 1944/1945, the volunteer men did not report an increased drive
for PA while starving [23]. To add to the complexity of altered PA in AN, the surrounding conditions
during the time of PA assessment might play a considerable role. When obese volunteers were
subjected to 24-h measurements of energy turnover within a metabolic chamber [24] for analysis of
spontaneous PA, with exercise being prohibited within the chamber, the authors hypothesized that
such forced reduction of voluntary exercise may have resulted in the partially observed increased
engagement in spontaneous PA [25]. Similarly, in 16 healthy, male volunteers who underwent 8 weeks
of experimental overfeeding, two-thirds of the increase in total daily energy expenditure was due to
increased non-exercise activity thermogenesis (NEAT) [26]. Individual variation in NEAT accounted
for the 10-fold differences in fat storage that occurred with overfeeding, suggesting that during positive
energy balance, high activation of NEAT results in difficulties to gain weight for some individuals.
The phenomenon of high NEAT and concomitantly energy needs of 4000 kcal/day to gain weight
was recently documented in a case report of a young woman with AN at the end of therapy [27].
We believe that it is important for the tailoring of suitable PA interventions for AN patients to find an
answer to the question whether increased low-level PA is an AN-specific phenotype that is linked with
physiological processes during starvation and refeeding, or whether such PA behavior is related to
restrictive treatment setting characteristics irrespective of AN, which may also be observable in other
populations. Therefore, the current restrictive handling of PA during AN treatment may need to be
reconsidered since an increase in low-level PA could provoke higher daily energy expenditure and
might hinder weight recovery. Increased voluntary exercise could be accompanied by a decrease in
spontaneous PA [25]. Concomitantly, Calogero et al. [28] investigated the effectiveness of an exercise
program in patients with eating disorders, reporting on weight improvements through this intervention
and concluding that patients in the exercise program may have been less likely to exercise secretly,
whereas patients in the control group may have exercised unsupervised.
A low admission BMI was identified as a major determinant for BMI increase in AN. Resting
energy expenditure proportionally declines with BMI [29], physiologically leading to a more rapid
weight regain at the beginning of treatment. Longer inpatient stay also predicted BMI increase which
may be at least in part explained by the rules in our adult treatment setting where patients were
discharged if they continuously failed to meet the expected weight targets. On the other hand, patients
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who stayed in treatment longer also had more time to gain weight. Since only a slight effect of PA on
BMI increase was observed and only by conducting an exploratory analysis, the admission BMI and
duration of stay had an overall much greater, independent and overriding predictive power on BMI
increase in AN. Whether an association between PA and weight trajectory in AN can be detected may
depend on certain study characteristics, i.e., measurement technique and time point of PA assessment.
There was no association between (I) PA duration at different MET intensities and daily steps at
inpatient discharge and BMI at 1-year follow up [30]; (II) PA level operationalized as the average
acceleration in m/s2/min from both feet and BMI or rate of weight gain in AN patients admitted to an
inpatient unit [11], and (III) time spent on feet at low-weight within 2 weeks of hospital admission
or 1-month post-treatment discharge and 12 months BMI trajectory [8]. However, a longer on-feet
duration at the inpatient weight restored time point was associated with a more rapid decrease in BMI
over the 12 months following discharge [8]. Interestingly, a retrospective study applying questionnaires
for PA assessment 6 months and 1 week prior to inpatient admission in 20 adolescents with AN found
that an increase in PA—and not a decrease in food intake—was associated with the need for inpatient
treatment [31]. These findings give rise to at least some effect of PA on the weight and illness trajectory
of AN, and stress the need for further, systematic studies on this topic.
In the present study, no linear and direct associations between sleep duration and recumbency,
conceptualized as physical inactivity parameters, and weight gain during AN treatment existed.
Similarly, others could not find associations between sleep patterns and BMI [32], or between changes
in sleep patterns and changes in BMI [33]. In the latter study, there was a significant direct association
between baseline sleep time and BMI. In the present study, the contribution of sleep duration to
variance of BMI increase was only of minor effect size. However, unexpectedly, in a multivariable
model, the duration of sleep was inversely associated with BMI increase. In obesity, short sleep duration
is known to be associated with increased food intake and excess body weight [34,35]. Whether this
link also applies to patients with AN needs further investigation.
While we used objective PA assessments at standardized time points close to hospital admission,
which are different from other studies that assessed PA across various stages of AN treatment [11],
our findings also need to be interpreted within their limitations. Firstly, the validity of the SenseWear
armband in severely underweight AN patients is unknown, and raw data and algorithms within the
armband software are not accessible to researchers. Nonetheless, we consider this technology suitable
for PA detection due to its easy handling compared to other devices [8] and the fact that multiple
sensors enable the distinction between various types of PA, the recording of actual on-body time as
well as time spent on sleep [14]. Second, whether our controls were of comparable socioeconomic
background, and whether the wearing of the armband motivated them to work out more than usual
remains unclear. Given that PA analysis was conducted between hospitalized AN patients and healthy
controls within their everyday environment and thus in two very different settings, comparability
of data may be argued. As a consequence, PA patterns of the patients in the present study may
not be representative of other patients with AN under other types of care. However, finding a
suitable control group for hospitalized patients is difficult, as healthy people are not hospitalized, and
hospitalized patients for other reasons than AN are likely to suffer from a medical condition which
affects PA patterns.
In conclusion, we found that AN patients spent more time engaging in light, and less time
engaging in vigorous intensity PA than controls, and that the BMI increase during inpatient treatment
was predicted by low admission BMI and longer inpatient treatment. Furthermore, high step count and
time in light-intensity PA only emerged as potential predictors of lower BMI increase in an exploratory
and non-linear model. This latter finding indicates that the effect of PA on the disease course of AN
should be quantified and clarified further and that more complex models may need to be employed in
future research on this topic. Since PA behavior is likely influenced by multiple factors including age,
psychological and nutritional parameters, assessment of these potential modifiers in future studies
may contribute to a better understanding of PA variability in AN.
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